The European Union's drugs regulator on Thursday recommended approval for Eisai and Biogen's Leqembi in some patients with ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, it ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Berislav Zlokovic, MD, PhD, a prominent ...

The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Researchers discovered that the enzyme TYK2 alters the tau protein, promoting its accumulation in the brain, a process linked ...

During National Family Caregivers Month in November, the Alzheimer’s Association is encouraging dementia caregivers to make their own health an equal priority as they navigate the demands and stresses ...

University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...

In 2022, The Tulsa Opera partnered with a program called Songs By Heart that works to bring live, interactive, music therapy ...